O'Brien Kathrine 4

4 · AMAG PHARMACEUTICALS INC. · Filed Apr 12, 2019

Form 4

Period: 2019-04-10

Director

Transactions

Award
Stock Option (Right to Buy)
2019-04-10+6,000→ 6,000 total
Exercise: $12.92Exp: 2029-04-10→ Common Stock (6,000 underlying)
Award
Stock Option (Right to Buy)
2019-04-10+1,200→ 1,200 total
Exercise: $12.92Exp: 2029-04-10→ Common Stock (1,200 underlying)
Award
Common Stock
2019-04-10+564→ 564 total

Footnotes (4)

[F1]Each restricted stock unit represents a contingent right to receive one share of Common Stock of AMAG Pharmaceuticals, Inc. (the "Issuer"). These shares of Common Stock are issuable pursuant to a grant of restricted stock units pursuant to the Issuer's Fourth Amended & Restated 2007 Equity Incentive Plan, as amended (the "Plan") that will vest on May 1, 2019; however, delivery of the shares is deferred until the earlier of (a) one year from the date of grant and (b) the date of the director's separation from service to the Issuer.
[F2]Not applicable.
[F3]Grant of stock option pursuant to the Plan. This option will vest and become exercisable in twenty-four equal monthly installments over two years from the date of grant.
[F4]Grant of stock option pursuant to the Plan. This option will vest and become exercisable on May 1, 2019.

Documents

1 file